In your practice, how early do you recommend performing whole exome sequencing and in what tumors, and is it critical to detect mutations, translocations, allelic fractions, and amplifications?

In your practice, how early do you recommend performing whole exome sequencing and in what tumors, and is it critical to detect mutations, translocations, allelic fractions, and amplifications?

In your practice, how early do you recommend performing whole exome sequencing and in what types of tumors, and is it critical to detect mutations, translocations, allelic fractions, and amplifications?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jean-Charles Soria, MD

Jean-Charles Soria, MD

Professor of Medicine and Medical Oncology South-Paris University Cancer Specialist Institut Gustave Roussy (IGR) Paris, France